Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 14, 2001

View Archived Issues

New Target For Thrombotic Drugs Could Increase Safety

Genset Cuts Back Genomics Focus, Moves On To Discovery

British Biotech's Marimistat Fails In Promising Indication

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Despite Resistance In France, Chirac Sees Place For GM Crops

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Curacyte Gets Into Full Swing With US$6.5M Seed Financing

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

French Advancing Legislation To Allow Therapeutic Cloning

Hybrigenics, Servier Collaborate On Discovery Of Cancer Drugs

Medica Strengthens Position With Kinase-Targeting Filings

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...